Related Experiment Video

Updated: Mar 24, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K

Determinants of early life immune responses to RSV infection

Tracy J Ruckwardt1, Kaitlyn M Morabito1, Barney S Graham1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA.

Current Opinion in Virology
|March 18, 2016
PubMed

Insights

Developing an effective respiratory syncytial virus (RSV) vaccine for infants is challenging due to their immature immune systems. Strategies like vaccinating older children or pregnant mothers may offer indirect protection.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Respiratory syncytial virus (RSV) causes substantial illness and death globally, particularly in infants.
  • Current vaccines do not adequately protect against severe RSV disease, representing a significant unmet medical need.
  • Infants' immature immune systems pose challenges for developing effective active immunization strategies.

Purpose of the Study:

  • To explore strategies for protecting infants from severe respiratory syncytial virus disease.
  • To address the unmet need for an effective RSV vaccine in early life.
  • To consider indirect immunization approaches for infant protection.

Main Methods:

  • Reviewing the impact of RSV on infants.
  • Analyzing the complexities of early-life immune responses for vaccine design.
  • Evaluating potential vaccine delivery methods and target populations.

Main Results:

  • Infant immunological immaturity complicates direct vaccine approaches.
  • Targeting early immune responses and controlling primary antigen exposure are key considerations.
  • Indirect protection via vaccination of older children or pregnant mothers is a viable alternative.

Conclusions:

  • Protecting infants from RSV requires innovative vaccine strategies.
  • Understanding and leveraging early-life immunity is crucial for vaccine development.
  • Indirect immunization offers a promising pathway to reduce infant RSV burden until they can mount effective responses.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.6K
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

11.1K

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
5
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
10
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K